zerbaxa
merck sharp & dohme b.v. - ceftolozane sulfat, natrium tazobactam - bakterieinfektioner - antibakterielle midler til systemisk brug, - zerbaxa is indicated for the treatment of the following infections in adults:complicated intra abdominal infections;acute pyelonephritis;complicated urinary tract infections;hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap). det bør overvejes at officielle vejledning om hensigtsmæssig brug af antibakterielle midler..
lyomet 1000 mg depottabletter
strides pharma (cyprus) limited - metforminhydrochlorid - depottabletter - 1000 mg
lyomet 750 mg depottabletter
strides pharma (cyprus) limited - metforminhydrochlorid - depottabletter - 750 mg
vancomycin "strides" 250 mg kapsler, hårde
strides pharma (cyprus) limited - vancomycinhydrochlorid - kapsler, hårde - 250 mg
zodediab mr 30 mg tabletter med modificeret udløsning
strides pharma (cyprus) limited - gliclazid - tabletter med modificeret udløsning - 30 mg
zodediab mr 60 mg tabletter med modificeret udløsning
strides pharma (cyprus) limited - gliclazid - tabletter med modificeret udløsning - 60 mg
amitriptylin "strides" 22,1 mg filmovertrukne tabletter
strides pharma (cyprus) limited - amitriptylinhydrochlorid - filmovertrukne tabletter - 22,1 mg
amitriptylin "strides" 44,2 mg filmovertrukne tabletter
strides pharma (cyprus) limited - amitriptylinhydrochlorid - filmovertrukne tabletter - 44,2 mg
amitriptylin "strides" 8,8 mg filmovertrukne tabletter
strides pharma (cyprus) limited - amitriptylinhydrochlorid - filmovertrukne tabletter - 8,8 mg
gabapentin "strides" 100 mg kapsler, hårde
strides pharma (cyprus) limited - gabapentin - kapsler, hårde - 100 mg